FDA issues emergency authorization for COVID-19 convalescent plasma treatment
5 years ago 1 min read
The FDA is issuing an emergency authorization for convalescent plasma treatment in hospitalized COVID-19 patients, agency officials told reporters on a call Sunday.
More Stories
Record Korean Cases; Trader’s Guide to Rollout: Virus Update
California Hits Record; Trader’s Guide to Rollout: Virus Update
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push